- In June 2024, significant advancements in CRISPR-Cas9 technology reshaped the global plant breeding landscape, with growing emphasis on non-GMO applications to enhance drought tolerance, pest resistance, and photosynthetic efficiency in staple crops. Researchers from the University of California, Berkeley and the University of Illinois demonstrated how CRISPR-Cas9 could be used to increase gene expression in rice by modifying upstream regulatory DNA—boosting photosynthesis without introducing foreign genes. These innovations are particularly relevant to regions such as Latin America, where climate-resilient agriculture is critical, and adoption of such technologies continues to expand
- In September 2024, Corteva Inc. partnered with U.S.-based gene editing innovator Pairwise, investing $25 million to form a five-year joint venture aimed at accelerating CRISPR-based crop development. The collaboration, launched under Corteva Catalyst™, focuses on enhancing climate resilience, yield, and nutritional value in staple crops such as corn and soy. By leveraging Pairwise’s Fulcrum™ gene editing platform, the initiative seeks to deliver precise, non-GMO improvements that address global food security challenges. With Corteva’s strong presence in Latin America, these advancements are expected to benefit farmers across the region
- In September 2023, Bayer AG expanded its fruits and vegetables portfolio by acquiring the strawberry breeding program of the UK’s National Institute of Agricultural Botany (NIAB). With over 40 years of horticultural innovation at East Malling, the program includes the Malling™ Fruits portfolio and focuses on developing premium genetics for protected and open-field strawberry cultivation. This strategic acquisition enables Bayer to meet rising global demand for year-round, high-quality strawberries. Although not specific to Latin America, Bayer’s strong presence in the region suggests these innovations will be tailored for local markets
- In March 2023, Corteva Agriscience unveiled a groundbreaking gene-editing technology designed to enhance disease resistance in elite corn hybrids. Using CRISPR, the innovation strategically combines and repositions native disease-resistant traits within the corn genome, targeting major threats such as Northern leaf blight, Southern rust, and anthracnose stalk rot. This approach minimizes production stress, boosts plant health, and increases yield potential. While initially focused on North American conditions, the technology is scalable and holds significant promise for corn-producing regions in Latin America, where Corteva maintains a strong presence
- In August 2022, Bayer AG expanded its investment in sustainable agriculture by acquiring a 65% majority stake in CoverCress Inc., a U.S.-based producer of low-carbon oilseed crops. Developed from field pennycress using advanced breeding and gene-editing techniques, CoverCress™ offers the dual benefits of a cover crop and a harvestable source for renewable diesel and animal feed. This strategic acquisition aligns with Bayer’s sustainability goals by helping reduce nitrogen fertilizer dependence and agricultural carbon emissions. While focused on North America, the technology holds promise for adoption in Latin America, where Bayer maintains a strong agricultural footprint
